• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

替马沙星、托氟沙星(A-61827)及其他五种氟喹诺酮类药物的体外活性

In-vitro activities of temafloxacin, tosufloxacin (A-61827) and five other fluoroquinolone agents.

作者信息

Barry A L, Jones R N

机构信息

Clinical Microbiology Institute, Tualatin, Oregon 97062.

出版信息

J Antimicrob Chemother. 1989 Apr;23(4):527-35. doi: 10.1093/jac/23.4.527.

DOI:10.1093/jac/23.4.527
PMID:2745259
Abstract

Tosufloxacin (A-61827) is the tosylate salt of A-60969 (T-3262). Temafloxacin (A-62254) is the hydrochloride salt of A-63004. Both compounds were tested against 945 aerobic bacterial isolates and their in-vitro activities were compared to those of five other fluoroquinolones. Ciprofloxacin and tosufloxacin were similar in their activity against the Enterobacteriaceae and Pseudomonas species. Temafloxacin and ofloxacin were similar in their activity against the Gram-negative bacilli. Strains that were susceptible to ciprofloxacin were also susceptible to ofloxacin, temafloxacin and tosufloxacin. Against nalidixic acid-resistant enteric bacilli, the potency of all seven fluoroquinolones was compromised. Enoxacin and fleroxacin were the least active drugs against Gram-positive species. Tosufloxacin was particularly active against the Gram-positive species; ciprofloxacin, difloxacin and temafloxacin were less active.

摘要

妥舒沙星(A - 61827)是A - 60969(T - 3262)的甲苯磺酸盐。替马沙星(A - 62254)是A - 63004的盐酸盐。对这两种化合物针对945株需氧细菌分离株进行了测试,并将它们的体外活性与其他五种氟喹诺酮类药物的活性进行了比较。环丙沙星和妥舒沙星对肠杆菌科和假单胞菌属的活性相似。替马沙星和氧氟沙星对革兰氏阴性杆菌的活性相似。对环丙沙星敏感的菌株对氧氟沙星、替马沙星和妥舒沙星也敏感。对于耐萘啶酸的肠道杆菌,所有七种氟喹诺酮类药物的效力均受到影响。依诺沙星和氟罗沙星对革兰氏阳性菌的活性最低。妥舒沙星对革兰氏阳性菌特别有效;环丙沙星、双氟沙星和替马沙星的活性较低。

相似文献

1
In-vitro activities of temafloxacin, tosufloxacin (A-61827) and five other fluoroquinolone agents.替马沙星、托氟沙星(A-61827)及其他五种氟喹诺酮类药物的体外活性
J Antimicrob Chemother. 1989 Apr;23(4):527-35. doi: 10.1093/jac/23.4.527.
2
In vitro activities of sparfloxacin, tosufloxacin, ciprofloxacin, and fleroxacin.司帕沙星、妥舒沙星、环丙沙星和氟罗沙星的体外活性。
Antimicrob Agents Chemother. 1991 May;35(5):955-60. doi: 10.1128/AAC.35.5.955.
3
The in-vitro activity of tosufloxacin, a new fluorinated quinolone, compared with that of ciprofloxacin and temafloxacin.新型氟喹诺酮类药物托氟沙星与环丙沙星和替马沙星的体外活性比较。
J Antimicrob Chemother. 1991 Nov;28(5):719-25. doi: 10.1093/jac/28.5.719.
4
Cross-resistance and cross-susceptibility between fluoroquinolone agents.氟喹诺酮类药物之间的交叉耐药性和交叉敏感性。
Eur J Clin Microbiol Infect Dis. 1991 Dec;10(12):1013-8. doi: 10.1007/BF01984922.
5
Temafloxacin: in vitro comparison with five other antibacterial agents.替马沙星:与其他五种抗菌剂的体外比较
Chemotherapy. 1991;37(2):98-105. doi: 10.1159/000238840.
6
In vitro activities of tosufloxacin, temafloxacin, and A-56620 against pathogens of diarrhea.妥舒沙星、替马沙星和A-56620对腹泻病原体的体外活性
Antimicrob Agents Chemother. 1990 Feb;34(2):368-70. doi: 10.1128/AAC.34.2.368.
7
In-vitro activity of tosufloxacin, a new quinolone antibacterial agent.
J Antimicrob Chemother. 1992 Jun;29(6):639-47. doi: 10.1093/jac/29.6.639.
8
In vitro activity of CP-74,667. A new fluoroquinolone compared with other quinolones.
Diagn Microbiol Infect Dis. 1992 Sep-Oct;15(7):613-20. doi: 10.1016/0732-8893(90)90039-x.
9
Correlation of in vitro activities of the fluoroquinolones to their in vivo efficacies.氟喹诺酮类药物的体外活性与其体内疗效的相关性。
Drugs Exp Clin Res. 1988;14(6):375-8.
10
Comparison of in vitro antimicrobial activity of AM-1155 with those of tosufloxacin and fleroxacin against clinical isolates of Neisseria gonorrhoeae harboring quinolone resistance alterations in GyrA and ParC.AM-1155与妥舒沙星和氟罗沙星对携带GyrA和ParC喹诺酮耐药性改变的淋病奈瑟菌临床分离株的体外抗菌活性比较。
Chemotherapy. 1997 Jul-Aug;43(4):239-44. doi: 10.1159/000239573.

引用本文的文献

1
Enhanced Neuronal Survival and Neurite Outgrowth Triggered by Novel Small Organic Compounds Mimicking the LewisX Glycan.新型小分子化合物模拟 LewisX 聚糖,触发神经元存活和突起生长
Mol Neurobiol. 2018 Oct;55(10):8203-8215. doi: 10.1007/s12035-018-0953-8. Epub 2018 Mar 8.
2
Current perspectives on glycopeptide resistance.糖肽类耐药性的当前观点
Clin Microbiol Rev. 1995 Oct;8(4):585-615. doi: 10.1128/CMR.8.4.585.
3
Efficacy and ocular penetration of sparfloxacin in experimental streptococcal endophthalmitis.司帕沙星在实验性链球菌性眼内炎中的疗效及眼内通透性
Antimicrob Agents Chemother. 1993 Apr;37(4):633-6. doi: 10.1128/AAC.37.4.633.
4
New quinolones and gram-positive bacteria.新型喹诺酮类药物与革兰氏阳性菌
Antimicrob Agents Chemother. 1994 Feb;38(2):163-9. doi: 10.1128/AAC.38.2.163.
5
Topical 0.3% ciprofloxacin, norfloxacin, and ofloxacin in treatment of bacterial keratitis: a new method for comparative evaluation of ocular drug penetration.局部应用0.3%环丙沙星、诺氟沙星和氧氟沙星治疗细菌性角膜炎:一种比较评估眼用药物渗透性的新方法。
Br J Ophthalmol. 1995 Jun;79(6):606-9. doi: 10.1136/bjo.79.6.606.
6
Temafloxacin disk potency and tentative interpretive criteria for susceptibility tests.替马沙星纸片效价及药敏试验暂行解释标准。
J Clin Microbiol. 1989 Dec;27(12):2861-3. doi: 10.1128/jcm.27.12.2861-2863.1989.
7
Susceptibility of enterococci and epidemiology of enterococcal infection in the 1980s.20世纪80年代肠球菌的易感性及肠球菌感染的流行病学。
Epidemiol Infect. 1989 Dec;103(3):403-13. doi: 10.1017/s0950268800030806.
8
Comparative in vitro activity of WIN 57273, a new fluoroquinolone antimicrobial agent.新型氟喹诺酮抗菌剂WIN 57273的体外活性比较
Antimicrob Agents Chemother. 1990 Jun;34(6):1154-9. doi: 10.1128/AAC.34.6.1154.
9
Comparative in vitro activities of several new fluoroquinolones and beta-lactam antimicrobial agents against community isolates of Streptococcus pneumoniae.几种新型氟喹诺酮类和β-内酰胺类抗菌药物对社区分离肺炎链球菌的体外活性比较
Antimicrob Agents Chemother. 1990 Mar;34(3):467-9. doi: 10.1128/AAC.34.3.467.
10
In vitro activity of tosufloxacin (A-61827; T-3262) against selected genital pathogens.妥舒沙星(A-61827;T-3262)对特定生殖道病原体的体外活性。
Antimicrob Agents Chemother. 1990 Jun;34(6):971-3. doi: 10.1128/AAC.34.6.971.